Anti-anti-suit injunctions: filers reveal importance of new orders
IPCom, Nokia and two car companies say the success of the new order shows that forum-shopping does not fly with European courts and – if that continues – anti-suit injunctions will not become popular as a ‘stalling tool’. Read more...
What the US-UK trade deal documents actually reveal
Generics and innovator sources from the pharma industry explain why documents from US and UK trade discussions do not point to the US trying to extend pharmaceutical patents. Read more...
Open source case prompts patent troll litigation fears
Software stakeholders including the Linux Foundation, Qualcomm and Unified Patents are concerned that RPI v Gnome has opened the door to open source NPE litigation. Read more...
Dismantling the patent system not a 'silver bullet' to lower drug prices
In-house counsel from pharma innovators say the IP system is unfairly under attack for rising drug prices and that new drugs will not reach the market without patents. Read more...
